Corcept Therapeutics CORT
NASDAQ CORT
$111.62 -1.18 (-1.05%)
As of: Sep 4, 2026 · 3:59 PM EDT

Corcept Therapeutics (CORT) FCF Margin (QoQ) (2012 - 2026)

Analysis

Corcept Therapeutics (CORT) FCF Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Corcept Therapeutics 11.76 Bn 11.46 Bn 252.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,240.00
Mar 31, 2026 -2,929.00
Dec 31, 2025 -724.00
Sep 30, 2025 348.00
Jun 30, 2025 1,979.00
Mar 31, 2025 -2,998.00
Dec 31, 2024 -630.00
Sep 30, 2024 1,436.00
Jun 30, 2024 871.00
Mar 31, 2024 1,210.00
Dec 31, 2023 -3,869.00
Sep 30, 2023 694.00
Jun 30, 2023 1,127.00
Mar 31, 2023 -780.00
Dec 31, 2022 -36.00
Sep 30, 2022 1,530.00
Jun 30, 2022 -2,018.00
Mar 31, 2022 -1,234.00
Dec 31, 2021 -55.00
Sep 30, 2021 222.00